"
Team:Trieste/sandbox/home
From 2012.igem.org
(edit news order, add dates) |
(add summary) |
||
| Line 10: | Line 10: | ||
<h1 id="h1_rt" class="main_tit"><div>Our team</div></h1> | <h1 id="h1_rt" class="main_tit"><div>Our team</div></h1> | ||
<div id="box_left"><!-- start box_main --> | <div id="box_left"><!-- start box_main --> | ||
| - | <h2>WE PRESENT YOU | + | <h2>WE PRESENT YOU THE JOLLY JOCARE</h2> |
| - | + | ||
<p> | <p> | ||
| - | + | Recent studies have evidenced that having a beneficial and healthy | |
| + | intestinal microflora is very important for human health. Our | ||
| + | aim is to modify a bacteria normally found in human gut and | ||
| + | create a safe, controllable and versatile molecular platform | ||
| + | which can be used to produce a wide range of molecules leading | ||
| + | to a beneficial probiotic. For this purpose we have chosen the | ||
| + | E. coli strain Nissle 1917 which has been used for many years as | ||
| + | a probiotic. We designed a robust gene guard system regulated | ||
| + | by a novel and easy to control inducible cumate switch that | ||
| + | activates the production of a human antimicrobial peptide LL-37 | ||
| + | that can kill the bacteria and also avoid horizontal transfer. | ||
| + | </p> | ||
| + | <p> | ||
| + | The safe probiotic constructed here can be used to produce nutritious, preventive or therapeutic molecules. For example, we have used it to produce an antibody against the emerging virus, Norovirus. | ||
</p> | </p> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
</div> <!-- end box_left --> | </div> <!-- end box_left --> | ||
<div id="box_main"> <!-- start box_main --> | <div id="box_main"> <!-- start box_main --> | ||
Revision as of 18:40, 7 September 2012
Our Project
Latest news
Our team
WE PRESENT YOU THE JOLLY JOCARE
Recent studies have evidenced that having a beneficial and healthy intestinal microflora is very important for human health. Our aim is to modify a bacteria normally found in human gut and create a safe, controllable and versatile molecular platform which can be used to produce a wide range of molecules leading to a beneficial probiotic. For this purpose we have chosen the E. coli strain Nissle 1917 which has been used for many years as a probiotic. We designed a robust gene guard system regulated by a novel and easy to control inducible cumate switch that activates the production of a human antimicrobial peptide LL-37 that can kill the bacteria and also avoid horizontal transfer.
The safe probiotic constructed here can be used to produce nutritious, preventive or therapeutic molecules. For example, we have used it to produce an antibody against the emerging virus, Norovirus.
